Floatz logo

Therapeutic Asset Ratings

1,055 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Luveltamab Tazevibulin
Primary Peritoneal Carcinoma
Sutro Biopharma, Inc.P2/3D (30)
4-phenylbutyrate
Hereditary Disease
Children's Hospital of Fudan UniversityP2/3NR ()
Acetylcysteine
Drug Allergy
Fakultas Kedokteran Universitas IndonesiaP2/3NR ()
Acetylcysteine
Kidney Disorder
Fakultas Kedokteran Universitas IndonesiaP2/3NR ()
apc101
Postherpetic Neuralgia
Andros Pharmaceuticals Co., Ltd.P2/3NR ()
Camerlizumab
Hepatocellular Carcinoma
Shanghai Zhongshan HospitalP2/3NR ()
Cetuxima-Β
Colorectal Cancer
Sun Yat-sen UniversityP2/3NR ()
Compound Cantharides
Hepatocellular Carcinoma
Shanghai Zhongshan HospitalP2/3NR ()
Hmpl-453
Intrahepatic Cholangiocarcinoma
HutchmedP2/3NR ()
IPN60340
Acute Myeloid Leukemia
IpsenP2/3NR ()
Magnesium Diasporal
Non-Small Cell Lung Carcinoma
Swiss Cancer InstituteP2/3NR ()
Maralixibat
Constipation Disorder
Children's Hospital Los AngelesP2/3NR ()
Met-4
Neoplasm
University Health Network, TorontoP2/3NR ()
Minocycline
Arterial Occlusion
Xiang LuoP2/3NR ()
Minocycline
Intracerebral Hemorrhage
Joyce ChenP2/3NR ()
Minocycline
Disease
Joyce ChenP2/3NR ()
Minocycline
Vertebrobasilar Insufficiency
Xiang LuoP2/3NR ()
mlc1501
Intracranial Embolism
Moleac Pte Ltd.P2/3NR ()
Monosialotetrahexose Ganglioside Sodium
Chemotherapy-Induced Neuropathy
Qilu Pharmaceutical Co., Ltd.P2/3NR ()
Naben®
Treatment-Refractory Schizophrenia
SyneuRx International (Taiwan) CorpP2/3NR ()
Neovasculgen®
Interstitial Cystitis
JSC NextGenP2/3NR ()
Nivestim
Toxic Epidermal Necrolysis
Hospices Civils de LyonP2/3NR ()
Prax-562
Developmental And Epileptic Encephalopathy, 13
Praxis Precision MedicinesP2/3NR ()
Recombinant Human Acid Sphingomyelinase
Niemann-Pick Disease
SanofiP2/3NR ()
Sebacoyl Dinalbuphine Ester
Chronic Pain Syndrome
Dalin Tzu Chi General HospitalP2/3NR ()
Showing 1026 to 1050 of 1,055 assets
PreviousPage 42 of 43Next